EXPO vs ACN vs EPAM vs G vs IBM

For growth investors, EPAM Systems, Inc.

(EPAM) is the stronger pick with 15. 4% revenue growth year-over-year, versus 4. 2% for Exponent, Inc. (EXPO). Genpact Limited (G) offers the better valuation at 11. 0x trailing P/E (8. 6x forward), making it the more compelling value choice. Analysts rate Exponent, Inc. (EXPO) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Genpact Limited (G) is the cheapest at 11.

0x versus Exponent, Inc. at 30. 6x. On forward P/E, EPAM Systems, Inc. is actually cheaper at 8. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Genpact Limited wins at 0. 58x versus Exponent, Inc. 's 5. 18x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, International Business Machines Corporation (IBM) delivered a total return of +90.

2%, compared to -77. 3% for EPAM Systems, Inc. (EPAM). Over 10 years, the gap is even starker: EXPO returned +186. 1% versus G's +42. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Genpact Limited (G) is the lower-risk stock at 0.

67β versus EPAM Systems, Inc. 's 1. 21β — meaning EPAM is approximately 81% more volatile than G relative to the S&P 500. On balance sheet safety, EPAM Systems, Inc. (EPAM) carries a lower debt/equity ratio of 4% versus 2% for International Business Machines Corporation — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), EPAM Systems, Inc.

(EPAM) is pulling ahead at 15. 4% versus 4. 2% for Exponent, Inc. (EXPO). On earnings-per-share growth, the picture is similar: International Business Machines Corporation grew EPS 73. 7% year-over-year, compared to -14. 3% for EPAM Systems, Inc.. Over a 3-year CAGR, G leads at 5. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Exponent, Inc.

(EXPO) is the more profitable company, earning 18. 2% net margin versus 6. 9% for EPAM Systems, Inc. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXPO leads at 20. 6% versus 9. 6% for EPAM. At the gross margin level — before operating expenses — IBM leads at 59. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Genpact Limited (G) is the more undervalued stock at a PEG of 0. 58x versus Exponent, Inc. 's 5. 18x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, EPAM Systems, Inc. (EPAM) trades at 8. 2x forward P/E versus 30. 9x for Exponent, Inc. — 22. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EPAM: 88. 7% to $197. 00.

In this comparison, ACN (3.

2% yield), IBM (2. 9% yield), G (1. 9% yield), EXPO (1. 9% yield) pay a dividend. EPAM does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Genpact Limited (G) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

67), 1. 9% yield). Both have compounded well over 10 years (G: +42. 5%, EPAM: +48. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (EXPO (Industrials) and ACN (Technology) and EPAM (Technology) and G (Technology) and IBM (Technology)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: EXPO is a small-cap quality compounder stock; ACN is a mid-cap deep-value stock; EPAM is a small-cap high-growth stock; G is a small-cap deep-value stock; IBM is a large-cap quality compounder stock. EXPO, ACN, G, IBM pay a dividend while EPAM does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.